GENETICALLY CHANGED CELLS AND THEIR USE IN PROPHYLAXIS OR TREATING OF DISEASES
Cells (A) for use in gene therapy are produced by: (a) isolating mononuclear, non-adherent cells (B) from blood or cell-containing body fluids; (b) culturing (B) in a medium containing gangliosides, phospholipids, glycolipids and/ or growth factors for endothelial cells (EC), including those factors...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | cze ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HAVEMANN KLAUS MULLER ROLF DR SEDLACEK HANS-HARALD DR |
| description | Cells (A) for use in gene therapy are produced by: (a) isolating mononuclear, non-adherent cells (B) from blood or cell-containing body fluids; (b) culturing (B) in a medium containing gangliosides, phospholipids, glycolipids and/ or growth factors for endothelial cells (EC), including those factors that regulate differentiation, survival, migration and/or vascularisation; (c) optionally immortalising the cells of (a) or (b) by: (i) transformation with, or activation of, an oncogene; or (ii) inactivation of a suppressor gene; and (d) optionally treating cells of (a)-(c) with a nucleic acid construct (C) for gene therapy that includes an effector gene which, by choice of suitable promoter systems, can be activated in a cell-, cell cycle- or virus-specific manner and/or by hypoxia. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CZ227198A3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CZ227198A3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CZ227198A33</originalsourceid><addsrcrecordid>eNqFyrEKwjAQgOEsDqI-g_cCDraDOh6Xa3MQkpKLYF1KkTiJFur7o4O7088H_9KElgNnIfS-B3L4tQVi7xUwWMiOJcFZGSRAl2Lneo8XUYgJcmLMElqIDVhRRmVdm8V9fMxl8-vKbBvO5HZleg1lnsZbeZb3QNeqOuxPR6zr_8cHRY0tkg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GENETICALLY CHANGED CELLS AND THEIR USE IN PROPHYLAXIS OR TREATING OF DISEASES</title><source>esp@cenet</source><creator>HAVEMANN KLAUS ; MULLER ROLF DR ; SEDLACEK HANS-HARALD DR</creator><creatorcontrib>HAVEMANN KLAUS ; MULLER ROLF DR ; SEDLACEK HANS-HARALD DR</creatorcontrib><description>Cells (A) for use in gene therapy are produced by: (a) isolating mononuclear, non-adherent cells (B) from blood or cell-containing body fluids; (b) culturing (B) in a medium containing gangliosides, phospholipids, glycolipids and/ or growth factors for endothelial cells (EC), including those factors that regulate differentiation, survival, migration and/or vascularisation; (c) optionally immortalising the cells of (a) or (b) by: (i) transformation with, or activation of, an oncogene; or (ii) inactivation of a suppressor gene; and (d) optionally treating cells of (a)-(c) with a nucleic acid construct (C) for gene therapy that includes an effector gene which, by choice of suitable promoter systems, can be activated in a cell-, cell cycle- or virus-specific manner and/or by hypoxia.</description><edition>6</edition><language>cze ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990217&DB=EPODOC&CC=CZ&NR=227198A3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990217&DB=EPODOC&CC=CZ&NR=227198A3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HAVEMANN KLAUS</creatorcontrib><creatorcontrib>MULLER ROLF DR</creatorcontrib><creatorcontrib>SEDLACEK HANS-HARALD DR</creatorcontrib><title>GENETICALLY CHANGED CELLS AND THEIR USE IN PROPHYLAXIS OR TREATING OF DISEASES</title><description>Cells (A) for use in gene therapy are produced by: (a) isolating mononuclear, non-adherent cells (B) from blood or cell-containing body fluids; (b) culturing (B) in a medium containing gangliosides, phospholipids, glycolipids and/ or growth factors for endothelial cells (EC), including those factors that regulate differentiation, survival, migration and/or vascularisation; (c) optionally immortalising the cells of (a) or (b) by: (i) transformation with, or activation of, an oncogene; or (ii) inactivation of a suppressor gene; and (d) optionally treating cells of (a)-(c) with a nucleic acid construct (C) for gene therapy that includes an effector gene which, by choice of suitable promoter systems, can be activated in a cell-, cell cycle- or virus-specific manner and/or by hypoxia.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFyrEKwjAQgOEsDqI-g_cCDraDOh6Xa3MQkpKLYF1KkTiJFur7o4O7088H_9KElgNnIfS-B3L4tQVi7xUwWMiOJcFZGSRAl2Lneo8XUYgJcmLMElqIDVhRRmVdm8V9fMxl8-vKbBvO5HZleg1lnsZbeZb3QNeqOuxPR6zr_8cHRY0tkg</recordid><startdate>19990217</startdate><enddate>19990217</enddate><creator>HAVEMANN KLAUS</creator><creator>MULLER ROLF DR</creator><creator>SEDLACEK HANS-HARALD DR</creator><scope>EVB</scope></search><sort><creationdate>19990217</creationdate><title>GENETICALLY CHANGED CELLS AND THEIR USE IN PROPHYLAXIS OR TREATING OF DISEASES</title><author>HAVEMANN KLAUS ; MULLER ROLF DR ; SEDLACEK HANS-HARALD DR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CZ227198A33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>cze ; eng</language><creationdate>1999</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>HAVEMANN KLAUS</creatorcontrib><creatorcontrib>MULLER ROLF DR</creatorcontrib><creatorcontrib>SEDLACEK HANS-HARALD DR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HAVEMANN KLAUS</au><au>MULLER ROLF DR</au><au>SEDLACEK HANS-HARALD DR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GENETICALLY CHANGED CELLS AND THEIR USE IN PROPHYLAXIS OR TREATING OF DISEASES</title><date>1999-02-17</date><risdate>1999</risdate><abstract>Cells (A) for use in gene therapy are produced by: (a) isolating mononuclear, non-adherent cells (B) from blood or cell-containing body fluids; (b) culturing (B) in a medium containing gangliosides, phospholipids, glycolipids and/ or growth factors for endothelial cells (EC), including those factors that regulate differentiation, survival, migration and/or vascularisation; (c) optionally immortalising the cells of (a) or (b) by: (i) transformation with, or activation of, an oncogene; or (ii) inactivation of a suppressor gene; and (d) optionally treating cells of (a)-(c) with a nucleic acid construct (C) for gene therapy that includes an effector gene which, by choice of suitable promoter systems, can be activated in a cell-, cell cycle- or virus-specific manner and/or by hypoxia.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | cze ; eng |
| recordid | cdi_epo_espacenet_CZ227198A3 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | GENETICALLY CHANGED CELLS AND THEIR USE IN PROPHYLAXIS OR TREATING OF DISEASES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T06%3A27%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HAVEMANN%20KLAUS&rft.date=1999-02-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECZ227198A3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |